2,2'-(3,6-dioxocyclohexa-1,4-diene-1,4-diyl)bis(azanediyl)dibenzoic acid

ID: ALA475959

Chembl Id: CHEMBL475959

Cas Number: 4046-39-3

PubChem CID: 317883

Max Phase: Preclinical

Molecular Formula: C20H14N2O6

Molecular Weight: 378.34

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1C=C(Nc2ccccc2C(=O)O)C(=O)C=C1Nc1ccccc1C(=O)O

Standard InChI:  InChI=1S/C20H14N2O6/c23-17-10-16(22-14-8-4-2-6-12(14)20(27)28)18(24)9-15(17)21-13-7-3-1-5-11(13)19(25)26/h1-10,21-22H,(H,25,26)(H,27,28)

Standard InChI Key:  ZICRATSMKAPMHF-UHFFFAOYSA-N

Associated Targets(Human)

DNM1 Tbio Dynamin-1 (215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

nadE NH(3)-dependent NAD(+) synthetase (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus anthracis (2936 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dnm2 Dynamin-2 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 378.34Molecular Weight (Monoisotopic): 378.0852AlogP: 2.53#Rotatable Bonds: 6
Polar Surface Area: 132.80Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.51CX Basic pKa: CX LogP: 3.47CX LogD: -3.04
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.56Np Likeness Score: 0.12

References

1. Moro WB, Yang Z, Kane TA, Brouillette CG, Brouillette WJ..  (2009)  Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs).,  19  (7): [PMID:19249205] [10.1016/j.bmcl.2009.02.034]
2. MacGregor KA, Abdel-Hamid MK, Odell LR, Chau N, Whiting A, Robinson PJ, McCluskey A..  (2014)  Development of quinone analogues as dynamin GTPase inhibitors.,  85  [PMID:25084145] [10.1016/j.ejmech.2014.06.070]

Source